Stocks Overview

LAST PRICE
41.7700
TODAY'S CHANGE (%)
0.0000 (0.0000%)

Bid / Lots
41.7700/ 2
Ask / Lots
43.9500/ 1
Open / Previous Close
43.7800 / 41.7700
Day Range
Low 41.4100
High 44.0000
52 Week Range
Low 31.5200
High 54.9800
Volume
935,376
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Wednesday's close: 41.45
Time	Volume	RARE
09:32 ET	49724	43.55
09:34 ET	2653	43.11
09:36 ET	2704	43.195
09:38 ET	4352	42.93
09:39 ET	5307	43
09:41 ET	1900	42.935
09:43 ET	4433	42.84
09:45 ET	2131	42.67
09:48 ET	11694	42.69
09:50 ET	1000	42.83
09:52 ET	300	42.83
09:54 ET	12098	42.54
09:56 ET	9647	42.57
09:57 ET	1700	42.42
09:59 ET	5880	42.4
10:01 ET	9969	42.405
10:03 ET	1600	42.3
10:06 ET	7820	42.565
10:08 ET	2106	42.56
10:10 ET	1112	42.535
10:12 ET	931	42.565
10:14 ET	600	42.6475
10:15 ET	1860	42.615
10:19 ET	904	42.625
10:21 ET	420	42.6882
10:24 ET	522	42.64
10:26 ET	700	42.61
10:28 ET	3483	42.5
10:30 ET	826	42.5
10:32 ET	1149	42.515
10:35 ET	2818	42.61
10:37 ET	452	42.6655
10:39 ET	734	42.62
10:42 ET	1081	42.56
10:44 ET	2669	42.675
10:46 ET	1768	42.84
10:48 ET	1406	42.9
10:50 ET	800	42.775
10:51 ET	635	42.62
10:53 ET	200	42.7089
10:55 ET	2594	42.65
10:57 ET	715	42.71
11:00 ET	300	42.7825
11:02 ET	400	42.815
11:04 ET	1100	42.91
11:06 ET	1400	42.81
11:08 ET	300	42.925
11:11 ET	700	42.97
11:13 ET	873	42.96
11:15 ET	500	42.99
11:18 ET	1181	42.94
11:20 ET	400	42.9
11:22 ET	908	42.925
11:24 ET	976	42.88
11:26 ET	2500	42.966
11:27 ET	1848	42.78
11:29 ET	300	42.76
11:33 ET	3908	42.96
11:36 ET	300	42.97
11:38 ET	2575	42.925
11:40 ET	200	42.945
11:42 ET	300	42.945
11:44 ET	300	42.945
11:45 ET	13344	42.89
11:47 ET	2297	42.88
11:51 ET	200	42.89
11:56 ET	2768	42.76
11:58 ET	600	42.73
12:00 ET	327	42.635
12:02 ET	978	42.58
12:03 ET	2073	42.675
12:05 ET	200	42.7
12:07 ET	100	42.7
12:09 ET	600	42.655
12:12 ET	4493	42.8
12:14 ET	3349	42.73
12:16 ET	100	42.77
12:18 ET	1186	42.69
12:20 ET	717	42.72
12:21 ET	200	42.68
12:23 ET	1453	42.71
12:25 ET	722	42.75
12:27 ET	370	42.755
12:30 ET	1194	42.695
12:32 ET	221	42.62
12:34 ET	871	42.68
12:36 ET	1400	42.61
12:38 ET	1389	42.59
12:39 ET	300	42.63
12:41 ET	500	42.64
12:43 ET	713	42.59
12:45 ET	1644	42.605
12:48 ET	535	42.63
12:50 ET	1268	42.75
12:52 ET	950	42.7
12:54 ET	100	42.686
12:56 ET	417	42.68
12:57 ET	700	42.67
12:59 ET	509	42.68
01:01 ET	1506	42.735
01:03 ET	900	42.71
01:06 ET	1134	42.75
01:08 ET	740	42.71
01:10 ET	1100	42.65
01:12 ET	1145	42.71
01:14 ET	2255	42.71
01:15 ET	1000	42.75
01:17 ET	2174	42.67
01:19 ET	300	42.62
01:21 ET	200	42.6496
01:24 ET	2718	42.71
01:26 ET	742	42.805
01:28 ET	415	42.81
01:30 ET	499	42.89
01:32 ET	300	42.86
01:33 ET	7240	42.88
01:35 ET	5271	42.77
01:37 ET	1400	42.75
01:39 ET	431	42.76
01:42 ET	400	42.795
01:44 ET	200	42.76
01:46 ET	52136	42.76
01:48 ET	3011	42.69
01:50 ET	1600	42.59
01:51 ET	810	42.565
01:55 ET	5415	42.4
01:57 ET	400	42.405
02:00 ET	200	42.46
02:02 ET	700	42.48
02:04 ET	300	42.43
02:06 ET	2900	42.42
02:08 ET	700	42.42
02:09 ET	4072	42.31
02:11 ET	400	42.32
02:15 ET	5095	42.225
02:18 ET	200	42.255
02:20 ET	300	42.25
02:22 ET	1163	42.21
02:24 ET	516	42.23
02:26 ET	1700	42.2194
02:27 ET	1350	42.2048
02:29 ET	300	42.14
02:31 ET	709	42.17
02:36 ET	507	42.22
02:38 ET	1500	42.19
02:40 ET	500	42.2
02:42 ET	100	42.22
02:44 ET	1750	42.18
02:45 ET	300	42.145
02:47 ET	845	42.13
02:51 ET	2178	42.11
02:54 ET	600	42.12
02:56 ET	1921	42.04
02:58 ET	100	42.06
03:00 ET	1200	42.0825
03:02 ET	1400	41.98
03:03 ET	2037	42.01
03:07 ET	200	42.025
03:09 ET	300	42.06
03:12 ET	1577	42.03
03:14 ET	600	42.01
03:16 ET	1449	42.005
03:18 ET	2350	42.04
03:20 ET	1798	42
03:21 ET	300	41.96
03:23 ET	3841	41.83
03:25 ET	15314	41.575
03:27 ET	1540	41.59
03:30 ET	12100	41.795
03:32 ET	4301	41.665
03:34 ET	2884	41.605
03:36 ET	3146	41.481
03:38 ET	1420	41.65
03:39 ET	7286	41.49
03:41 ET	1427	41.52
03:43 ET	4360	41.46
03:45 ET	2812	41.41
03:48 ET	1556	41.5
03:50 ET	3741	41.475
03:52 ET	12850	41.84
03:54 ET	8644	41.9
03:56 ET	14778	41.93
03:57 ET	13732	41.845
03:59 ET	26070	41.77

Data delayed at least 15 minutes.

Yesterday
- DJ Ultragenyx Pharma Raised to Buy From Neutral by Goldman Sachs, from 17 hours ago by Dow Jones
  17 hours ago by Dow Jones
Jun 4, 2024
- Ultragenyx to Participate at Goldman Sachs 45th Annual Global Healthcare Conference, from 4:05PM ET on Tuesday Jun 04, 2024 by Dow Jones
  4:05PM ET on Tuesday Jun 04, 2024 by Dow Jones
May 31, 2024
- DJ Ultragenyx Pharma Is Maintained at Neutral by Wedbush, from 1:50PM ET on Friday May 31, 2024 by Dow Jones
  1:50PM ET on Friday May 31, 2024 by Dow Jones
- DJ Ultragenyx Pharma Is Maintained at Buy by B of A Securities, from 1:12PM ET on Friday May 31, 2024 by Dow Jones
  1:12PM ET on Friday May 31, 2024 by Dow Jones
- DJ Ultragenyx Pharma Is Maintained at Buy by Canaccord Genuity, from 1:09PM ET on Friday May 31, 2024 by Dow Jones
  1:09PM ET on Friday May 31, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesRARE Ultragenyx Pharmaceutical Inc	3.3B	-5.2x	---
United StatesFOLD Amicus Therapeutics Inc	2.9B	-20.8x	---
United StatesGH Guardant Health Inc	3.3B	-7.4x	---
United StatesGMAB Genmab A/S	18.6B	23.7x	+22.71%
United StatesAXSM Axsome Therapeutics Inc	3.5B	-11.7x	---
United StatesMOR MorphoSys AG	2.8B	-5.4x	---
As of 2024-06-07

Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company. The Company is focused on the identification, acquisition, development, and commercialization of novel products for the treatment of serious rare and ultrarare genetic diseases. Its therapies and clinical-stage pipeline consist of four product categories: biologics, small molecules, AAV gene therapy, and nucleic acid product candidates. The Company’s four approved product candidates include Crysvita (burosumab) for the treatment of X-linked hypophosphatemia (XLH), and tumor-induced osteomalacia (TIO), Mepsevii (vestronidase alfa) for the treatment of mucopolysaccharidosis VII (MPSVII) or Sly Syndrome, Dojolvi (triheptanoin) for the treatment of long-chain fatty acid oxidation disorders (LC-FAOD), and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia (HoFH). Its clinical product candidates include DTX401, DTX301, and UX701. DTX401 for the treatment of glycogen storage disease type la.

Contact Information

Headquarters: 60 Leveroni CtNOVATO, CA, United States 94949-5746
Phone: 415-483-8800
Fax: 415-483-8810

Executives

Independent Director: Daniel Welch
President, Chief Executive Officer, Director: Emil Kakkis
Chief Financial Officer, Executive Vice President, Corporate Strategy: Howard Horn
Executive Vice President, Chief Technical Operations Officer and Gene Therapy Operations: Dennis Huang
Executive Vice President, Chief Legal Officer, General Counsel: Karah Parschauer

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$3.3B
Revenue (TTM)	$442.6M
Shares Outstanding	83.1M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.60
EPS	$-8.02
Book Value	$3.35
P/E Ratio	-5.2x
Price/Sales (TTM)	7.5
Price/Cash Flow (TTM)	---
Operating Margin	-131.15%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Ultragenyx Pharmaceutical Inc
NASDAQ:RAREUnited States

Search Criteria

Charts

Recent News

Yesterday

DJ Ultragenyx Pharma Raised to Buy From Neutral by Goldman Sachs, from 17 hours ago by Dow Jones

Jun 4, 2024

Ultragenyx to Participate at Goldman Sachs 45th Annual Global Healthcare Conference, from 4:05PM ET on Tuesday Jun 04, 2024 by Dow Jones

May 31, 2024

DJ Ultragenyx Pharma Is Maintained at Neutral by Wedbush, from 1:50PM ET on Friday May 31, 2024 by Dow Jones

DJ Ultragenyx Pharma Is Maintained at Buy by B of A Securities, from 1:12PM ET on Friday May 31, 2024 by Dow Jones

DJ Ultragenyx Pharma Is Maintained at Buy by Canaccord Genuity, from 1:09PM ET on Friday May 31, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar